医学伦理研究助手
前沿
论文精读

论文 · 动物实验

DNM2 型腓骨肌萎缩症源于施万细胞功能受损且治疗可逆性有限

Brain Commun · 2026年9月1日 · Goret 等 3 位作者

问这篇
一分钟了解要点新小鼠模型重现 DNM2 型腓骨肌萎缩症;症状出现后 AAV9 补充 DNM2 未见疗效。结果在 4 周龄症状出现后经鞘内注射 AAV9-DNM2(外周神经中 DNM2 表达增加约 1.9 倍),行为、电生理、结构和分子指标均无显著改善。

不需要生物学背景,多打比方

正在获取全文并生成讲解(拿不到全文就依据摘要)…

已等待 0 秒大约需要 10–20 秒

可以先看别的,做好了会自动出现在这里。

这篇还没有动画

动画会把研究的流程、作用机制和关键结果一步一步演示出来,每一步都标明出自原文哪里。制作大约需要一两分钟。

目前只拿到了摘要全文暂时拿不到(可能不是免费全文)。下面是论文摘要。

摘要Abstract

摘要第 1 段问这一段

Dominant loss-of-function mutations in DNM2 cause Charcot-Marie-Tooth neuropathy characterized by sensory and motor deficits associated with myelin and/or axonal abnormalities and muscle atrophy. Increasing DNM2 activity from embryogenesis has been reported to ameliorate neuromuscular phenotypes in the Dnm2K562E/+ Charcot-Marie-Tooth mouse; however, this model displays predominantly muscle pathology and limited nerve involvement, precluding rigorous evaluation of neuropathic mechanisms and potential therapies. Here, we performed comprehensive behavioural, electrophysiological, histological and molecular analyses to characterize the Dnm2K562E/ SC- mouse, which combines systemic heterozygosity for the common K562E mutation together with Schwann cell-specific deletion of wild-type Dnm2. This model faithfully reproduces key clinical and pathological features of DNM2-Charcot-Marie-Tooth, including motor deficits, reduced general force and coordination, and severe sensory and motor conduction deficits associated with axonal loss, demyelination and inflammation. Mechanistically, we delineate a coherent pathological sequence that explains the profound functional deficits. In particular, a downregulation of the transcription factor EGR2, a master regulator of myelin gene expression, and of the myelin protein MPZ correlates with demyelination. To evaluate the therapeutic potential of DNM2 supplementation, post-symptomatic intrathecal delivery of AAV9-DNM2 driven by the Schwann cell-specific MPZ promoter was performed at 4 weeks. Although DNM2 expression increased in peripheral nerves (∼1.9-fold), no significant improvements were observed across behavioural, electrophysiological, structural or molecular parameters. Together, these findings establish the Dnm2K562E/ SC- mouse as a robust preclinical model, recapitulating key features of DNM2-Charcot-Marie-Tooth, and provide crucial insight into the biological and temporal constraints that must guide future therapeutic strategies for DNM2-Charcot-Marie-Tooth.

这篇对您:
讲解或动画有问题: